Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

James Dalton

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Living Beings

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Mohler Michael L; Bohl Casey E; Jones Amanda; Coss Christopher C; Narayanan Ramesh; He Yali; Hwang Dong Jin; Dalton James T; Miller Duane D
Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.
Li Wei; Hwang Dong Jin; Cremer Dieter; Joo Hyun; Kraka Elfi; Kim Juhyun; Ross Charles R; Nguyen Viet Q; Dalton James T; Miller Duane D
Structure determination of chiral sulfoxide in diastereomeric bicalutamide derivatives.
Lu Yan; Li Chien-Ming; Wang Zhao; Ross Charles R; Chen Jianjun; Dalton James T; Li Wei; Miller Duane D
Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of James Dalton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Mohler Michael L; Bohl Casey E; Jones Amanda; Coss Christopher C; Narayanan Ramesh; He Yali; Hwang Dong Jin; Dalton James T; Miller Duane D
Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.
Journal of medicinal chemistry 2009;52(12):3597-617.
2009: Li Wei; Hwang Dong Jin; Cremer Dieter; Joo Hyun; Kraka Elfi; Kim Juhyun; Ross Charles R; Nguyen Viet Q; Dalton James T; Miller Duane D
Structure determination of chiral sulfoxide in diastereomeric bicalutamide derivatives.
Chirality 2009;21(6):578-83.
2009: Lu Yan; Li Chien-Ming; Wang Zhao; Ross Charles R; Chen Jianjun; Dalton James T; Li Wei; Miller Duane D
Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships.
Journal of medicinal chemistry 2009;52(6):1701-11.
2009: Phelps Mitch A; Lin Thomas S; Johnson Amy J; Hurh Eunju; Rozewski Darlene M; Farley Katherine L; Wu Di; Blum Kristie A; Fischer Beth; Mitchell Sarah M; Moran Mollie E; Brooker-McEldowney Michelle; Heerema Nyla A; Jarjoura David; Schaaf Larry J; Byrd John C; Grever Michael R; Dalton James T
Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia.
Blood 2009;113(12):2637-45.
2009: Yang Xiaojuan; Zhao Xiaobin; Phelps Mitch A; Piao Longzhu; Rozewski Darlene M; Liu Qing; Lee L James; Marcucci Guido; Grever Michael R; Byrd John C; Dalton James T; Lee Robert J
A novel liposomal formulation of flavopiridol.
International journal of pharmaceutics 2009;365(1-2):170-4.
2009: Jones Amanda; Chen Jiyun; Hwang Dong Jin; Miller Duane D; Dalton James T
Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception.
Endocrinology 2009;150(1):385-95.
2008: Narayanan Ramesh; Coss Christopher C; Yepuru Muralimohan; Kearbey Jeffrey D; Miller Duane D; Dalton James T
Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways.
Molecular endocrinology (Baltimore, Md.) 2008;22(11):2448-65.
2008: Bohl Casey E; Wu Zengru; Chen Jiyun; Mohler Michael L; Yang Jun; Hwang Dong Jin; Mustafa Suni; Miller Duane D; Bell Charles E; Dalton James T
Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.
Bioorganic & medicinal chemistry letters 2008;18(20):5567-70.
2008: Johnston Jeffrey S; Phelps Mitch A; Blum Kristie A; Blum William; Grever Michael R; Farley Katherine L; Dalton James T
Development and validation of a rapid and sensitive high-performance liquid chromatography-mass spectroscopy assay for determination of 17-(allylamino)-17-demethoxygeldanamycin and 17-(amino)-17-demethoxygeldanamycin in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;871(1):15-21.
2008: Phelps Mitch A; Rozewski Darlene M; Johnston Jeffrey S; Farley Katherine L; Albanese Katie A; Byrd John C; Lin Thomas S; Grever Michael R; Dalton James T
Development and validation of a sensitive liquid chromatography/mass spectrometry method for quantitation of flavopiridol in plasma enables accurate estimation of pharmacokinetic parameters with a clinically active dosing schedule.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;868(1-2):110-5.
2008: Chen Jianjun; Wang Zhao; Lu Yan; Dalton James T; Miller Duane D; Li Wei
Synthesis and antiproliferative activity of imidazole and imidazoline analogs for melanoma.
Bioorganic & medicinal chemistry letters 2008;18(11):3183-7.
2007: Li Wei; Lu Yan; Wang Zhao; Dalton James T; Miller Duane D
Synthesis and antiproliferative activity of thiazolidine analogs for melanoma.
Bioorganic & medicinal chemistry letters 2007;17(15):4113-7.
2007: Bohl Casey E; Wu Zengru; Miller Duane D; Bell Charles E; Dalton James T
Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design.
The Journal of biological chemistry 2007;282(18):13648-55.
2007: Li Wei; Wang Zhao; Gududuru Veeresa; Zbytek Blazej; Slominski Andrzej T; Dalton James T; Miller Duane D
Structure-activity relationship studies of arylthiazolidine amides as selective cytotoxic agents for melanoma.
Anticancer research 2007;27(2):883-8.
2007: Gao Wenqing; Dalton James T
Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs).
Drug discovery today 2007;12(5-6):241-8.
2007: Fang Lanyan; Holford Nicholas H G; Hinkle George; Cao Xianhua; Xiao Jim J; Bloomston Mark; Gibbs Seth; Saif Osama Habib Al; Dalton James T; Chan Kenneth K; Schlom Jeffery; Martin Edward W; Sun Duxin
Population pharmacokinetics of humanized monoclonal antibody HuCC49deltaCH2 and murine antibody CC49 in colorectal cancer patients.
Journal of clinical pharmacology 2007;47(2):227-37.
2007: Kearbey Jeffrey D; Gao Wenqing; Narayanan Ramesh; Fisher Scott J; Wu Di; Miller Duane D; Dalton James T
Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats.
Pharmaceutical research 2007;24(2):328-35.
2007: Byrd John C; Lin Thomas S; Dalton James T; Wu Di; Phelps Mitch A; Fischer Beth; Moran Mollie; Blum Kristie A; Rovin Brad; Brooker-McEldowney Michelle; Broering Sarah; Schaaf Larry J; Johnson Amy J; Lucas David M; Heerema Nyla A; Lozanski Gerard; Young Donn C; Suarez Jose-Ramon; Colevas A Dimitrios; Grever Michael R
Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia.
Blood 2007;109(2):399-404.
2006: Hwang Dong Jin; Yang Jun; Xu Huiping; Rakov Igor M; Mohler Michael L; Dalton James T; Miller Duane D
Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer.
Bioorganic & medicinal chemistry 2006;14(19):6525-38.
2006: Guan Na; Korukonda Rajani; Hurh Eunju; Schmittgen Thomas D; Donkor Isaac O; Dalton James T
Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines.
International journal of oncology 2006;29(3):655-63.
2006: Wu Zengru; Xing Xu; Bohl Casey E; Wisler James W; Dalton James T; Bell Charles E
Domain structure and DNA binding regions of beta protein from bacteriophage lambda.
The Journal of biological chemistry 2006;281(35):25205-14.
2006: Korukonda Rajani; Guan Na; Dalton James T; Liu Jiuyu; Donkor Isaac O
Synthesis, calpain inhibitory activity, and cytotoxicity of P2-substituted proline and thiaproline peptidyl aldehydes and peptidyl alpha-ketoamides.
Journal of medicinal chemistry 2006;49(17):5282-90.
2006: Gao Wenqing; Kim Juhyun; Dalton James T
Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands.
Pharmaceutical research 2006;23(8):1641-58.
2006: George Tesmol G; Johnsamuel Jayaseharan; Delfín Dawn A; Yakovich Adam; Mukherjee Mitali; Phelps Mitch A; Dalton James T; Sackett Dan L; Kaiser Marcel; Brun Reto; Werbovetz Karl A
Antikinetoplastid antimitotic activity and metabolic stability of dinitroaniline sulfonamides and benzamides.
Bioorganic & medicinal chemistry 2006;14(16):5699-710.
2006: Wu Di; George Tesmol G; Hurh Eunju; Werbovetz Karl A; Dalton James T
Pre-systemic metabolism prevents in vivo antikinetoplastid activity of N1,N4-substituted 3,5-dinitro sulfanilamide, GB-II-150.
Life sciences 2006;79(11):1081-93.
2006: Yang Jun; Bohl Casey E; Nair Vipin A; Mustafa Suni M; Hong Seoung Soo; Miller Duane D; Dalton James T
Preclinical pharmacology of a nonsteroidal ligand for androgen receptor-mediated imaging of prostate cancer.
The Journal of pharmacology and experimental therapeutics 2006;317(1):402-8.
2006: Taneja Samir S; Smith Matthew R; Dalton James T; Raghow Sharan; Barnette Gary; Steiner Mitchell; Veverka Karen A
Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy.
Expert opinion on investigational drugs 2006;15(3):293-305.
2006: Wu Di; Wu Zengru; Yang Jun; Nair Vipin A; Miller Duane D; Dalton James T
Pharmacokinetics and metabolism of a selective androgen receptor modulator in rats: implication of molecular properties and intensive metabolic profile to investigate ideal pharmacokinetic characteristics of a propanamide in preclinical study.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(3):483-94.
2006: Gao Wenqing; Wu Zengru; Bohl Casey E; Yang Jun; Miller Duane D; Dalton James T
Characterization of the in vitro metabolism of selective androgen receptor modulator using human, rat, and dog liver enzyme preparations.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(2):243-53.
2006: Gao Wenqing; Johnston Jeffrey S; Miller Duane D; Dalton James T
Interspecies differences in pharmacokinetics and metabolism of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylphenyl)-propionamide: the role of N-acetyltransferase.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(2):254-60.
2005: Chen Jiyun; Hwang Dong Jin; Chung Kiwon; Bohl Casey E; Fisher Scott J; Miller Duane D; Dalton James T
In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.
Endocrinology 2005;146(12):5444-54.
2005: Bohl Casey E; Miller Duane D; Chen Jiyun; Bell Charles E; Dalton James T
Structural basis for accommodation of nonsteroidal ligands in the androgen receptor.
The Journal of biological chemistry 2005;280(45):37747-54.
2005: Gao Wenqing; Reiser Peter J; Coss Christopher C; Phelps Mitch A; Kearbey Jeffrey D; Miller Duane D; Dalton James T
Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats.
Endocrinology 2005;146(11):4887-97.
2005: Kim Juhyun; Wu Di; Hwang Dong Jin; Miller Duane D; Dalton James T
The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators.
The Journal of pharmacology and experimental therapeutics 2005;315(1):230-9.
2005: Gao Wenqing; Bohl Casey E; Dalton James T
Chemistry and structural biology of androgen receptor.
Chemical reviews 2005;105(9):3352-70.
2005: Gududuru Veeresa; Hurh Eunju; Sullivan Joshua; Dalton James T; Miller Duane D
SAR studies of 2-arylthiazolidine-4-carboxylic acid amides: a novel class of cytotoxic agents for prostate cancer.
Bioorganic & medicinal chemistry letters 2005;15(18):4010-3.
2005: Chen Jiyun; Kim Juhyun; Dalton James T
Discovery and therapeutic promise of selective androgen receptor modulators.
Molecular interventions 2005;5(3):173-88.
2005: Bohl Casey E; Gao Wenqing; Miller Duane D; Bell Charles E; Dalton James T
Structural basis for antagonism and resistance of bicalutamide in prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(17):6201-6.
2005: Gududuru Veeresa; Hurh Eunju; Dalton James T; Miller Duane D
Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer.
Journal of medicinal chemistry 2005;48(7):2584-8.
2005: Chen Jiyun; Hwang Dong Jin; Bohl Casey E; Miller Duane D; Dalton James T
A selective androgen receptor modulator for hormonal male contraception.
The Journal of pharmacology and experimental therapeutics 2005;312(2):546-53.
2004: Gao Wenqing; Kearbey Jeffrey D; Nair Vipin A; Chung Kiwon; Parlow A F; Miller Duane D; Dalton James T
Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
Endocrinology 2004;145(12):5420-8.
2004: Gududuru Veeresa; Hurh Eunju; Dalton James T; Miller Duane D
Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer.
Bioorganic & medicinal chemistry letters 2004;14(21):5289-93.
2004: Gududuru Veeresa; Hurh Eunju; Durgam Gangadhar G; Hong Seoung Soo; Sardar Vineet M; Xu Huiping; Dalton James T; Miller Duane D
Synthesis and biological evaluation of novel cytotoxic phospholipids for prostate cancer.
Bioorganic & medicinal chemistry letters 2004;14(19):4919-23.
2004: Phelps Mitch A; Foraker Amy B; Gao Wenqing; Dalton James T; Swaan Peter W
A novel rhodamine-riboflavin conjugate probe exhibits distinct fluorescence resonance energy transfer that enables riboflavin trafficking and subcellular localization studies.
Molecular pharmaceutics 2004;1(4):257-66.
2004: Bohl Casey E; Chang Cheng; Mohler Michael L; Chen Jiyun; Miller Duane D; Swaan Peter W; Dalton James T
A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor.
Journal of medicinal chemistry 2004;47(15):3765-76.
2004: Kearbey J D; Wu D; Gao W; Miller D D; Dalton J T
Pharmacokinetics of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator.
Xenobiotica; the fate of foreign compounds in biological systems 2004;34(3):273-80.
2004: Marhefka Craig A; Gao Wenqing; Chung Kiwon; Kim Juhyun; He Yali; Yin Donghua; Bohl Casey; Dalton James T; Miller Duane D
Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators.
Journal of medicinal chemistry 2004;47(4):993-8.
2004: Wu Zengru; Gao Wenqing; Phelps Mitch A; Wu Di; Miller Duane D; Dalton James T
Favorable effects of weak acids on negative-ion electrospray ionization mass spectrometry.
Analytical chemistry 2004;76(3):839-47.
2003: Yates Charles R; Chang Cheng; Kearbey Jeffrey D; Yasuda Kazuto; Schuetz Erin G; Miller Duane D; Dalton James T; Swaan Peter W
Structural determinants of P-glycoprotein-mediated transport of glucocorticoids.
Pharmaceutical research 2003;20(11):1794-803.
2003: Yin Donghua; Gao Wenqing; Kearbey Jeffrey D; Xu Huiping; Chung Kiwon; He Yali; Marhefka Craig A; Veverka Karen A; Miller Duane D; Dalton James T
Pharmacodynamics of selective androgen receptor modulators.
The Journal of pharmacology and experimental therapeutics 2003;304(3):1334-40.
2003: Yin Donghua; Xu Huiping; He Yali; Kirkovsky Leonid I; Miller Duane D; Dalton James T
Pharmacology, pharmacokinetics, and metabolism of acetothiolutamide, a novel nonsteroidal agonist for the androgen receptor.
The Journal of pharmacology and experimental therapeutics 2003;304(3):1323-33.
2003: Yin Donghua; He Yali; Perera Minoli A; Hong Seoung Soo; Marhefka Craig; Stourman Nina; Kirkovsky Leonid; Miller Duane D; Dalton James T
Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.
Molecular pharmacology 2003;63(1):211-23.
2002: He Yali; Yin Donghua; Perera Minoli; Kirkovsky Leonid; Stourman Nina; Li Wei; Dalton James T; Miller Duane D
Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor.
European journal of medicinal chemistry 2002;37(8):619-34.
2002: Dalton James T; Yates Charles R; Yin Donghua; Straughn Arthur; Marcus Stuart L; Golub Allyn L; Meyer Marvin C
Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer.
The Journal of pharmacology and experimental therapeutics 2002;301(2):507-12.
2002: Rogers Tiffani D; Gades Naomi M; Kearby Jeffrey D; Virgous Carlos K; Dalton James T
Chronic restraint via tail immobilization of mice: effects on corticosterone levels and other physiologic indices of stress.
Contemporary topics in laboratory animal science / American Association for Laboratory Animal Science 2002;41(1):46-50.
2001: Dalton J T; Straughn A B; Dickason D A; Grandolfi G P
Predictive ability of level A in vitro-in vivo correlation for ringcap controlled-release acetaminophen tablets.
Pharmaceutical research 2001;18(12):1729-34.
2001: Zhu Z; Becklin R R; Desiderio D M; Dalton J T
Mass spectrometric characterization of the human androgen receptor ligand-binding domain expressed in Escherichia coli.
Biochemistry 2001;40(36):10756-63.
2001: Zhu Z; Becklin R R; Desiderio D M; Dalton J T
Identification of a novel phosphorylation site in human androgen receptor by mass spectrometry.
Biochemical and biophysical research communications 2001;284(3):836-44.
2001: Zhu Z; Bulgakov O V; Scott S S; Dalton J T
Recombinant expression and purification of human androgen receptor in a baculovirus system.
Biochemical and biophysical research communications 2001;284(3):828-35.
2001: Marhefka C A; Moore B M; Bishop T C; Kirkovsky L; Mukherjee A; Dalton J T; Miller D D
Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands.
Journal of medicinal chemistry 2001;44(11):1729-40.
2001: Yates C R; Vysokanov A; Mukherjee A; Ludden T M; Tolley E; Meduri G U; Dalton J T
Time-variant increase in methylprednisolone clearance in patients with acute respiratory distress syndrome: a population pharmacokinetic study.
Journal of clinical pharmacology 2001;41(4):415-24.
2000: Kirkovsky L; Mukherjee A; Yin D; Dalton J T; Miller D D
Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.
Journal of medicinal chemistry 2000;43(4):581-90.
1999: Mukherjee A; Kirkovsky L I; Kimura Y; Marvel M M; Miller D D; Dalton J T
Affinity labeling of the androgen receptor with nonsteroidal chemoaffinity ligands.
Biochemical pharmacology 1999;58(8):1259-67.
1999: Dalton J T; Meyer M C; Golub A L
Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs.
Drug metabolism and disposition: the biological fate of chemicals 1999;27(4):432-5.
1999: Dalton J T; Zhou D; Mukherjee A; Young D; Tolley E A; Golub A L; Meyer M C
Pharmacokinetics of aminolevulinic acid after intravesical administration to dogs.
Pharmaceutical research 1999;16(2):288-95.
1998: Dalton J T; Mukherjee A; Zhu Z; Kirkovsky L; Miller D D
Discovery of nonsteroidal androgens.
Biochemical and biophysical research communications 1998;244(1):1-4.
1997: Zhang X; De Los Angeles J E; He M Y; Dalton J T; Shams G; Lei L; Patil P N; Feller D R; Miller D D; Hsu F L
Medetomidine analogs as alpha 2-adrenergic ligands. 3. Synthesis and biological evaluation of a new series of medetomidine analogs and their potential binding interactions with alpha 2-adrenoceptors involving a "methyl pocket".
Journal of medicinal chemistry 1997;40(19):3014-24.
1996: Hughes T A; Heimberg M; Wang X; Wilcox H; Hughes S M; Tolley E A; Desiderio D M; Dalton J T
Comparative lipoprotein metabolism of myristate, palmitate, and stearate in normolipidemic men.
Metabolism: clinical and experimental 1996;45(9):1108-18.
1996: Zhang X; Yao X T; Dalton J T; Shams G; Lei L; Patil P N; Feller D R; Hsu F L; George C; Miller D D
Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis, and biological activity of conformationally restricted naphthalene derivatives of medetomidine.
Journal of medicinal chemistry 1996;39(15):3001-13.
1996: Mukherjee A; Kirkovsky L; Yao X T; Yates R C; Miller D D; Dalton J T
Enantioselective binding of Casodex to the androgen receptor.
Xenobiotica; the fate of foreign compounds in biological systems 1996;26(2):117-22.
1996: Han G; Israel M; Seshadri R; Dalton J T; Sweatman T W
Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat.
Cancer chemotherapy and pharmacology 1996;37(5):472-8.
1994: Dalton J T; Weintjes M G; Au J L
Effects of bladder resorption on pharmacokinetic data analysis.
Journal of pharmacokinetics and biopharmaceutics 1994;22(3):183-205.
1993: Yeh T K; Dalton J T; Au J L
High-performance liquid chromatographic determination of pentamidine in plasma.
Journal of chromatography 1993;622(2):255-61.
1993: Dalton J T; Au J L
2',3'-Dideoxyinosine is not metabolized in human placenta.
Drug metabolism and disposition: the biological fate of chemicals 1993;21(3):544-6.
1992: Dalton J T; Harrington M D; Au J L
Evidence of significant absorption of antipyrine from urinary bladder of rats.
The Journal of pharmacology and experimental therapeutics 1992;260(2):608-13.
1991: Dalton J T; Wientjes M G; Badalament R A; Drago J R; Au J L
Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.
Cancer research 1991;51(19):5144-52.
1991: Wientjes M G; Dalton J T; Badalament R A; Drago J R; Au J L
Bladder wall penetration of intravesical mitomycin C in dogs.
Cancer research 1991;51(16):4347-54.
1991: Au J L; Dalton J T; Wientjes M G
Evidence of significant absorption of sodium salicylate from urinary bladder of rats.
The Journal of pharmacology and experimental therapeutics 1991;258(1):357-64.
1991: Wientjes M G; Dalton J T; Badalament R A; Dasani B M; Drago J R; Au J L
A method to study drug concentration-depth profiles in tissues: mitomycin C in dog bladder wall.
Pharmaceutical research 1991;8(2):168-73.
1989: Dalton J T; Geuns E R; Au J L
High-performance liquid chromatographic determination of mitomycin C in rat and human plasma and urine.
Journal of chromatography 1989;495():330-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

James Dalton

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Living Beings

Procedures

Anatomy

Genes & Molecular Sequences

Disorders

Occupations

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of James Dalton (preview)

All Publications